Welcome to our dedicated page for Kelly Svcs news (Ticker: KELYA), a resource for investors and traders seeking the latest updates and insights on Kelly Svcs stock.
Kelly Services reports news about its specialty talent solutions business, including temporary staffing, outsourcing, consulting, permanent placement, and workforce management services for employers and job seekers. Company updates commonly address operating results, revenue trends, expense management, acquisition integration, technology modernization, share repurchases, dividends, and investor conference participation.
Recurring business developments also cover Kelly’s operating areas, including Enterprise Talent Management, Science, Engineering, Technology & Telecom, and Education. Education-related updates include Kelly Education workforce solutions for schools and the Kelly Pediatric Therapy brand, which provides pediatric therapy and behavioral health services across early intervention, school-based services, and outpatient clinic care.
Kelly (Nasdaq: KELYA, KELYB) reported Q1 2026 revenue of $1.0 billion, down 10.7% year-over-year, with an underlying decline of approximately 3.3% after discrete customer impacts. Q1 operating loss was $5.1 million; adjusted EBITDA was $15.8 million (margin 1.5%), down 54.7% year-over-year. The company affirmed unchanged 2026 guidance, expects Q2 revenue decline of 7–9% and at least 2.5% adjusted EBITDA margin, and anticipates return to organic revenue growth and margin expansion in H2 2026. A quarterly dividend of $0.075 per share was declared.
Kelly Pediatric Therapy (KELYA) on May 4, 2026 announced winners of its annual Provider of the Year awards during Teacher Appreciation Week. Two national winners—Dyishia Womack (behavioral therapy) and Amanda Myers (occupational therapy)—each receive a $5,000 bonus plus $1,500 for a school donation; a runner-up received $1,000 plus $500 for a school.
The program recognizes school-nominated providers for clinical skill, compassion, and student-centered work across Pennsylvania.
Kelly Education (NYSE:KELYA) named Esther Yardumian-Smyth and Celia Effrig its 2026 Substitute Educators of the Year during Teacher Appreciation Week, May 4, 2026. Winners receive $5,000 each and $1,500 to a school; 2026 adds formal runner-up recognition.
Runner-ups receive $1,000 plus $500 for a school. Stories are posted at the company website.
Kelly (NYSE:KELYA) will release first-quarter 2026 earnings before market open on May 7, 2026 and host a live webcast conference call with financial analysts at 9:00 a.m. ET.
A financial presentation and live webcast link will be available on the company Investor Relations Events & Presentations page; a replay will be posted within one hour after the event.
Kelly (Nasdaq: KELYA) named Joel Leege president of Kelly Science, Engineering, Technology & Telecom (SETT), effective Mar. 16, 2026. He joins Kelly's senior leadership team and reports to CEO Chris Layden.
Leege brings nearly three decades of staffing and talent solutions experience, including double-digit organic growth at Red Oak Technologies and leadership roles at Randstad Digital, Prosum, Fahrenheit IT, and Kforce. His mandate is to accelerate profitable growth across life sciences, engineering, technology, and telecom by building on SETT’s scale and capabilities.
Kelly (Nasdaq: KELYA) will participate in two upcoming virtual investor conferences in March 2026. Truist Securities Inaugural Human Capital Virtual Conference is scheduled for March 13, 2026, and the Sidoti Small-Cap Virtual Conference is scheduled for March 19, 2026.
CEO Chris Layden, CFO Troy Anderson, and Head of Investor Relations Scott Thomas will hold one-on-one investor meetings. Kelly’s investor presentation is available on the company website.
Kelly Education (NYSE:KELYA) relaunched Pediatric Therapeutic Services as Kelly Pediatric Therapy on March 4, 2026, completing integration that began with Kelly's 2022 acquisition of PTS.
The rebrand unifies workforce and clinical capabilities, expands the clinical team and infrastructure, and positions the business to deliver a full continuum of pediatric therapy across early intervention, school-based services, and outpatient care.
Kelly (Nasdaq: KELYA, KELYB) reported FY2025 revenue of $4.3 billion (down 1.9%) and FY free cash flow of $114 million, a sixfold increase versus prior year. Q4 revenue was $1.1 billion (down 11.9%) with Q4 adjusted EBITDA margin of 2.0% and FY adjusted EBITDA margin of 2.6%. The company completed $10 million of Class A repurchases in Q4, deployed $158 million of capital in 2025, declared a $0.075 quarterly dividend, and expects organic revenue growth and margin expansion in H2 2026.
Kelly (Nasdaq: KELYA) appointed Patrick McCall as chief growth officer, effective Feb. 16, 2026. McCall will report to CEO Chris Layden and lead company-wide growth acceleration, strategic account management, new-logo acquisition, and a modern client-centric go-to-market model.
He brings 30 years of sales and operations experience, most recently as chief growth officer at AMN Healthcare, prior chief revenue officer at People2.0, and senior sales leadership at Randstad, where he oversaw a portfolio exceeding €3 billion.
Kelly (NYSE:KELYA) will release fourth-quarter and full-year 2025 earnings before market open on Thursday, February 12, 2026.
The company will publish a financial presentation and host a live webcast and conference call with analysts at 9:00 a.m. ET on February 12. A replay will be available within one hour via the Investor Relations Events & Presentations page.